Yamada Nobuhiro | Department Of Internal Medicine University Of Tsukuba Institute Of Clinical Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Polymorphisms of Apolipoprotein E and Methylenetetrahydrofolate Reductase in the Japanese Population
Distinct Effects of Pravastatin, Atorvastatin, and Simvastatin on Insulin Secretion from a β-cell Line, MIN6 Cells
Receptor-Type Protein Tyrosine Phosphatase ε (PTPεM) is a Negative Regulator of Insulin Signaling in Primary Hepatocytes and Liver
A Kindred of Familial Acromegaly without Evidence for Linkage to MEN-1 Locus
Proposed Guidelines for Hypertriglyceridemia in Japan with Non-HDL Cholesterol as the Second Target
Preventing Angiographic Progression of Coronary Atherosclerosis with Pravastatin
Prevalence of Metabolic Syndrome in the General Japanese Population in 2000
Polymorphisms in Four Genes Related to Triglyceride and HDL-cholesterol Levels in the General Japanese Population in 2000
Serum Lipid Survey and Its Recent Trend in the General Japanese Population in 2000
Clinical Effects of Rosuvastatin, a New HMG-CoA Reductase Inhibitor, in Japanese Patients With Primary Hypercholesterolemia : an Early Phase II Study
Clinical Features of Familial Hypercholesterolemia in Japan in a Database from 1996-1998 by the Research Committee of the Ministry of Health, Labour and Welfare of Japan
Mutations in Japanese Subjects with Primary Hyperlipidemia : Results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996
Effects of Pioglitazone Hydrochloride on Japanese Patients with Type 2 Diabetes Mellitus
Report of the Japan Atherosclerosis Society(JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
OE-044 Baseline Data of JPPP : The Large Randomized Controlled Trial of Primary Prevention by Enteric Coated Low-dose Aspirin in Japan.(Atherosclerosis, clinical(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circul
FRS-102 Event rates of Japanese patients with atherothrombosis : Results from the REduction of Atherothrombosis for Continued Health (REACH) Registry(Clinical Frontiers in Atherosclerosis(IHD),Featured Research Session,The 72nd Annual Scientific Meeting o
Prevalence, Awareness and Treatment of Cardiovascular Risk Factors in Patients at High Risk of Atherothrombosis in Japan : Results From Domestic Baseline Data of the REduction of Atherotherombosis for Continued Health(REACH) Registry
PJ-637 JPPP (Japanese Primary Prevention Project with Aspirin) : The Large-scale Randomized Controlled Trial of Primary Prevention by Enteric-coated Low-dose Aspirin(Atherosclerosis, clinical-13 (H) PJ107,Poster Session (Japanese),The 70th Anniversary Ann
5 International and National Cohort Study for the Clarification of the Characteristic of the Japanese Patients of Atherothrombosis(Comparison between Domestic and Overseas Clinical Evidence in Cardiology,Symposium 9 (SY9) (H),The 70th Anniversary Annual S
Characterization of Japanese Patients with Atherothrombosis by Participating in the International Registry of REACH (REduction of Atherothrombosis for Continued Health)(How to Make Japanese Original Evidence in Cardiology, The 69th Annual Scientific Meeti
Role of activin-A and follistatin in foam cell formation of THP-1 macrophages
Components of Metabolic Syndrome and their Combinations as Predictors of Cardiovascular Disease in Japanese Patients with Type 2 Diabetes. Implications for Improved Definition. Analysis from Japan Diabetes Complications Study (JDCS)

もっと見る

スポンサーリンク